Historically, medium-priority insider buys have outperformed the S&P 500 by a median ~1% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 7,520, 2022-2026). Past results don't predict the future. How we measure this ↗
Director Leslie J Parrette buys 340 IOSP shares at $74.09; stock down 40.8% from 52-week high.
Director Leslie J Parrette purchased 340 shares of Innospec Inc. at $74.09 on 2025-11-14, increasing holdings by 6.2% to 5,837 shares. The transaction occurs while the stock trades at $72.23, down 40.8% from its 52-week high of $121.93 and down 14.2% over the prior 90 days. Across his same-ticker history at IOSP, Parrette's prior four purchases show a 75% win rate at the 90-day mark (3 of 4 buys followed by positive returns), with returns ranging from +0.7% to +17.5% on the successful trades. However, the company's fundamentals show stress: annual revenue declined 5.3% year-over-year, and the P/E of 50.51 remains elevated despite the recent stock decline, suggesting limited margin of safety at current valuation.
IOSP VP & CFO Cleminson Ian sold 10,000 shares over 3 days (Aug 23-26) for $1.1M at blended avg $113.99
Ian Cleminson, VP & CFO of Innospec, sold 10,000 shares (43.5% of pre-transaction holdings) across 4 separate sales totaling $1,139,889.06 between August 23-26, 2024. The blended average price of $113.99 compares to a current price of $113.89, with the stock down 12.5% over the prior 30 days and down 13.4% from its 52-week high of $131.58. His single prior sale at IOSP in February 2024 showed a 90-day return of 5.1%, indicating the stock rose after that sale; this sale similarly occurred as the stock has declined recently. Without a 10b5-1 plan FLAG, the timing pattern at this ticker remains that 0 of 1 prior sells were well-timed at the 90-day mark. The company's fundamentals show flat annual revenue growth (-0.8%) and a P/E of 18.98 on $2.8B market cap.
Director Leslie J Parrette bought 143 IOSP shares at $105.84 on 2024-08-13, +3.1% of holdings; stock down 18.4% from 52-week high.
Director Parrette purchased 143 shares at $105.84, increasing holdings by 3.1% to 4,734 shares. The timing of this buy merits scrutiny: the prior buy at this ticker on 2024-05-16 returned -18.4% over 90 days, and the current stock is already down 18.4% from its 52-week high of $131.58 while also declining 14.4% over the last 30 days. Among his three prior IOSP trades, two were well-timed at the 90-day mark (2024-02-22 and 2023-05-10 both delivered positive 90-day returns), but the most recent buy (2024-05-16) suffered a sharp decline. The company fundamentals remain modest—revenue growth is flat at -0.8% year-over-year with a P/E of 17.90—and the position size remains small relative to the director's prior accumulation pattern. This transaction occurs against a backdrop of near-term weakness and provides limited material signal about conviction given the mixed outcome history at this specific ticker.
Add IOSP to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
